Advanced Search

Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2007 April;142(2) > Giornale Italiano di Dermatologia e Venereologia 2007 April;142(2):197-206

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEGIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases

Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,014

Frequency: Bi-Monthly

ISSN 0392-0488

Online ISSN 1827-1820

 

Giornale Italiano di Dermatologia e Venereologia 2007 April;142(2):197-206

CUTANEOUS MALIGNANCY UPDATE: MELANOMA IN 2007 

    REVIEWS

Sentinel lymph node biopsy for melanoma: therapeutic procedure or diagnostic test?

Vemuri B. 1, Sabel M. S. 2

1 Department of General Surgery University of Michigan Hospital Ann Arbor, MI, USA
2 Division of Surgical Oncology University of Michigan Comprehensive Cancer Center Ann Arbor, MI

Although sentinel lymph node (SLN) biopsy is considered standard of care by many surgical oncologists and dermatologists, it remains controversial among others. Clinical practitioners in both surgery and dermatology have used the same available evidence to both support and refute the sentinel node hypothesis and the role SLN biopsy should play in the management of cutaneous melanoma. Much of the disagreement centers on whether one views SLN biopsy as a therapeutic intervention meant to improve survival or a diagnostic test meant to stratify risk and select patients for further therapy. This article will review the available data, including the most recent data from the Multicenter Selective Lymphadenectomy Trial-I (MSLT-I), the first prospective randomized study of SLN biopsy in melanoma.

language: English


FULL TEXT  REPRINTS

top of page